Related content

Prognostic significance of p16 in locoregionally advanced head and neck cancer treated with concurrent 5-fluorouracil, hydroxyurea, cetuximab and intensity-modulated radiation therapy

By                              

Oncology Reports, Vol. 27, Iss. 5, 2012-01 ,pp. : 1580-1586

Spandidos Publications

Access to resources Recommend Favorite

Intensity modulated radiation therapy for retroperitoneal sarcoma: a case for dose escalation and organ at risk toxicity reduction

By Esiashvili Natia   Howell Rebecca   Ghavidel Shahram   Davis Lawrence W.   Koshy Mary   Landry Jerome C.   Lawson Joshua D.   Staley Charles A.  

Sarcoma, Vol. 7, Iss. 3-4, 2003-01 ,pp. : 137-148

Informa Healthcare

Access to resources Recommend Favorite

Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy

By Mundt A.J.   Mell L.K.   Roeske J.C.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 56, Iss. 5, 2003-08 ,pp. : 1354-1360

Elsevier

Access to resources Recommend Favorite

Intensity-Modulated Radiation Therapy for Breast Cancer: Improving Treatment Efficacy

By Vicini F.A.   Sharpe M.   Kestin L.   Martinez A.   Wong J.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 237-245

Adis International

Access to resources Recommend Favorite

Bone marrow-sparing intensity-modulated radiation therapy for Stage I seminoma

By Zilli Thomas   Boudreau Chantal   Doucet Robert   Alizadeh Moein   Lambert Carole   van Nguyen Thu   Taussky Daniel  

Acta Oncologica, Vol. 50, Iss. 4, 2011-05 ,pp. : 555-562

Informa Healthcare

Access to resources Recommend Favorite